Also known as an endoclip, the Instinct Plus Endoscopic Clipping Device is indicated for hemostasis and additional endoscopic applications, such as defect closure, endoscopic marking, and affixing esophageal self-expanding metal stents to the esophageal wall. Check out the resources below to see how these devices could help you to help your patients.
Unlike traditional therapies, Hemospray is a nonthermal, nontraumatic, noncontact modality that doesn’t require the precise targeting of other endoscopic devices. The Hemospray Endoscopic Hemostat creates a mechanical barrier over bleeding sites, and it has demonstrated successful results in a wide range of nonvariceal GI bleeds.
The publication of the largest multicenter international registry of Hemospray patients investigates the efficacy of Hemospray as a monotherapy, as part of a combination therapy, and as a rescue therapy.1 The registry shows that high hemostasis rates are achieved with Hemospray and that rebleed rates are in keeping with or lower than predicted rates.1
The information below was excerpted from a blog post available here: https://www.cookmedical.com/endoscopy/new-registry-demonstrates-hemosprays-high-success-rates/
Prospective data were collected from 314 patients across 12 centers. “These data show high rates of immediate hemostasis overall and in all subgroups.” “Hemospray was effective in achieving primary hemostasis with an overall hemostasis rate of 89.5%.”
The Instinct Plus Endoscopic Clipping Device—now with an updated indication for use—can be deployed simply in one step.
When used in an inpatient or acute-care setting, Hemospray Endoscopic Hemostat is approved for a new technology add-on payment by the Centers for Medicare & Medicaid Services.
Dr. Rehan Haidry and Dr. Mohamed Hussein discuss the latest clinical data on the use of Hemospray Endoscopic Hemostat in hemostasis.